Biotechnological Hub of the NIB (BTH-NIB)

The purpose of the investment project BTH-NIB is the assurance of the appropriate infrastructural conditions for the use of research and developmental opportunities in the fields of operation of the NIB.

Play Video About project
    Symposium on the environmental and climate changes
    with their impact on our waters and biodiversity
    Ljubljana, October 14 – 15, 2021
  • NIB plans to build a Biotechnological       Hub of the NIB (BTH-NIB)
    NIB plans to build a Biotechnological Hub of the NIB (BTH-NIB)
    The National Institute of Biology and the Ministry of Education, Science and Sport are starting to finance and implement the project "Biotechnological Hub of the National Institute of Biology".
  • LIFE NATURAVIVA: Biodiversity – Art of Life
    LIFE NATURAVIVA: Biodiversity – Art of Life
    Biodiversity collectively describes all living organisms. Included in biodiversity are also we, humans, but we have trouble understanding its significant importance for us and the threats for biodiversity.

Services and products

  • Agriculture Industry Services

    National Institute of Biology is authorized by the Ministry of Agriculture and the Environment to perform defined tasks of public service for the protection of plants.

  • Pharmaceutical and Biotechnology Industry Services

    We offer bioanalytical laboratory support, toxicology studies, genetic toxicology testing of different samples, residual DNA detection, improvements of production lines through systems biology, and cotoxicology studies.

  • Research equipment

    The big research equipment is used as support to our research and educational activities and serves technological development in co-operation with commercial enterprises.

  • Training and Related Services

    We offer hands on training, consulting and technical auditing, development of protocols and workflows, organization of workshops.

  • Mutagenicity analysis under GLP

    On the NIB we have certified GLP laboratory for testing mutagenicity with bacterial reverse mutation assay, or the Ames test (OECD 471).


Co-financed by the Republic of Slovenia and the European Union
from the European Social Fund.